Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Galimedix Therapeutics Inc.

United States 3704 Calvend Lane, 20895-3112, United States

About the sponsor

Galimedix Therapeutics Inc. is focused on clinical research in ophthalmology, with attention to degenerative retinal disease and structural preservation of the eye.

  • Retinal disorders
  • Vision-threatening disease
  • Age-related eye disease

The sponsor’s current clinical activity is centered on conditions affecting the retina and the progression of macular degeneration.

About Specializations

Galimedix Therapeutics Inc. runs clinical trials in conditions such as Dry age-related macular degeneration, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Dry age-related macular degeneration

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
  • Sponsor:Galimedix Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.